Edgestream Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-985
Closed -$227K 144
2016
Q3
$227K Buy
+985
New +$241K 0.13% 116
2016
Q2
Sell
-5,732
Closed -$1.54M 80
2016
Q1
$1.54M Buy
5,732
+4,032
+237% +$1.15M 1.73% 13
2015
Q4
$531K Sell
1,700
-23,599
-93% -$7.03M 1.52% 23
2015
Q3
$6.88M Sell
25,299
-8,828
-26% -$2.71M 12.02% 2
2015
Q2
$10.4M Buy
34,127
+22,129
+184% +$6.6M 7.14% 2
2015
Q1
$3.57M Buy
11,998
+10,033
+511% +$2.86M 4.65% 5
2014
Q4
$506K Sell
1,965
-9,948
-84% -$2.49M 1.16% 32
2014
Q3
$2.87M Sell
11,913
-4,882
-29% -$1.09M 2.51% 10
2014
Q2
$3.75M Buy
+16,795
New +$3.48M 2.39% 11

Other funds holding AGN

Edgestream Partners's AGN Position: Q4 2016 in Review

Edgestream Partners sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 985 shares — an estimated $227K sold.

Edgestream Partners first reported a position in AGN in Q2 2014 and held it in 9 quarters. The position peaked at $10.4M in Q2 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Edgestream Partners reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Edgestream Partners sold 985 Allergan plc shares in Q4 2016, an estimated $227K.
  • Edgestream Partners first reported a position in Allergan plc in Q2 2014 and held it in 9 quarters.
  • Edgestream Partners's Allergan plc position peaked at $10.4M in Q2 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Edgestream Partners's 13F filing for Q4 2016, filed 14 Feb 2017.